Inspire Investing, LLC Mirati Therapeutics, Inc. Transaction History

Inspire Investing, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$41.99 - $62.38 $18,307 - $27,197	-436 Reduced 6.23%	6,561 $385,000
Q3 2023 Oct 26, 2023	SELL	$27.8 - $45.35 $46,926 - $76,550	-1,688 Reduced 19.44%	6,997 $304,000
Q2 2023 Jul 31, 2023	BUY	$36.13 - $49.49 $48,197 - $66,019	1,334 Added 18.15%	8,685 $313,000
Q1 2023 Apr 24, 2023	BUY	$36.54 - $54.26 $78,049 - $115,899	2,136 Added 40.96%	7,351 $273,000
Q4 2022 Jan 26, 2023	BUY	$41.27 - $98.62 $93,022 - $222,289	2,254 Added 76.12%	5,215 $0
Q3 2022 Nov 07, 2022	BUY	$59.5 - $86.7 $176,179 - $256,718	2,961 New	2,961 $207,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.